Profile: Collegium Pharmaceutical Inc (COLL.OQ)

COLL.OQ on NASDAQ Stock Exchange Global Select Market

23 Aug 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Collegium Pharmaceutical, Inc., incorporated on July 01, 2014, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides extended-release drug delivery, while safeguarding against common methods of abuse and tampering, including crushing, chewing, and heating and injecting. In its DETERx technology, the Company combines active ingredients, such as oxycodone with fatty acid and waxes to form small spherical beads (microspheres) that are filled into a capsule.

Xtampza ER

Xtampza ER utilizes its DETERx technology platform. Xtampza ER is designed to provide adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Xtampza ER label supports alternate administration options, including, sprinkling the capsule contents on soft foods or into a cup, and then directly into the mouth, or through a gastrostomy or nasogastric feeding tube.


ONSOLIS is a Transmucosal Immediate-Release Fentanyl (TIRF) film indicated for the management of breakthrough pain in cancer patients (BTPc), 18 years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. ONSOLIS incorporates BioDelivery Sciences' BioErodible MucoAdhesive (BEMA) technology for rapid and controlled delivery of fentanyl, a Schedule II controlled substance, through buccal (inner cheek) administration.

The Company competes with Pfizer, Purdue Pharma, L.P., Inspirion Delivery Technologies, LLC, Endo Pharmaceuticals, Pernix, Egalet, Mallinckrodt, Teva Pharmaceutical Industries Ltd., Intellipharmaceutics, Pain Therapeutics and Endo Health Solutions Inc.

Company Address

Collegium Pharmaceutical Inc

100 Technology Center Dr
STOUGHTON   MA   02072-4710
P: +1781.7133699

Company Web Links